Capsule endoscopy in examination of esophagus for lesions after radiofrequency catheter ablation: a potential tool to select patients with increased risk of complications

Autor:	Alan Siu, R N Janice Santisi, Andrea Natale, John Vargo, Milan Dodig, R N Stacy Poe, Walid Saliba, Madhusudhan Sanaka, Luigi Di Biase, Bennie Upchurch
Rok vydání:	2010
Předmět:	Male medicine.medical_specialty Abdominal pain Chest Pain Time Factors Heart Diseases Radiofrequency ablation medicine.medical_treatment Catheter ablation Pilot Projects Chest pain Capsule Endoscopy Risk Assessment law.invention Esophageal Fistula Esophagus Capsule endoscopy law Predictive Value of Tests Risk Factors Physiology (medical) Atrial Fibrillation medicine Humans Aged Ohio Pain Measurement medicine.diagnostic_test business.industry Esophagogastroduodenoscopy Atrial fibrillation Nausea Pharyngitis Proton Pump Inhibitors Middle Aged medicine.disease Surgery Abdominal Pain medicine.anatomical_structure Treatment Outcome Catheter Ablation Female Radiology Esophagoscopy medicine.symptom Cardiology and Cardiovascular Medicine business
Zdroj:	Journal of cardiovascular electrophysiology. 21(8)
ISSN:	1540-8167
Popis:	Capsule Endoscopy in Examination of Esophagus. Background: Esophageal injury can result from left atrial radiofrequency ablation (RFA) therapy, with added concern because of its possible relationship to the development of atrial-esophageal (A-E) fistulas. Objective: Evaluate utility of esophageal capsule endoscopy to detect esophageal lesions as a complication of RFA therapy in the treatment of atrial fibrillation (AF). Methods: Consecutive patients with AF who underwent left atrial RFA therapy and received capsule endoscopy within 48 hours postablation. Video was reviewed by a single gastroenterologist. The medical records were also reviewed for symptoms immediately postablation and at the 3-month follow-up. Results: A total of 93 consecutive patients were included and 88 completed the study and were analyzed. The prevalence of esophageal lesions was 17% (15/88 patients). Nine percent (8/88) of these patients had lesions anatomically consistent with the location of the ablation catheter. Six patients with positive capsule findings had symptoms of chest pain (3/6, 50%), throat pain (2/6, 33%), nausea (1/6, 17%), and abdominal pain (1/6, 17%). An additional 24 patients were symptomatic postablation, but with normal capsule findings. All patients with identified lesions by capsule endoscopy received oral proton pump inhibitor therapy, and were instructed to contact the Cleveland Clinic in the event of worsening symptoms. No delayed complications were reported at the 3-month follow-up. Conclusion: This study supports the use of capsule endoscopy as a tool for the detection of esophageal injury post-RFA therapy. PillCam ESO is well tolerated and provides satisfactory images of the areas of interest in the esophagus without potential risk related to insufflation with regular esophagogastroduodenoscopy. (J Cardiovasc Electrophysiol, Vol. 21, pp. 839-844, August 2010)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b33436b6f4f4cf6cdd4359815d2d50 https://pubmed.ncbi.nlm.nih.gov/20367656 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.